Los puntos clave no están disponibles para este artículo en este momento.
Dasatinib, an oral inhibitor of ABL and SRC family tyrosine kinases, is an effective drug for patients with Philadelphia chromosome positive (Ph+) leukemia, especially for those who develop resista...
Shimokaze et al. (Mon,) studied this question.